Biolife solutions inc (BLFS)
CashFlow / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,041

-5,877

-5,902

-5,333

-4,995

-4,589

-4,160

-3,893

-3,300

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-1,657

-16,797

-24,883

-29,451

-25,005

1,815

266

-1,641

3,228

-2,515

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,111

-1,153

-1,369

-1,659

-1,559

-1,685

-1,623

-1,956

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities
Depreciation

718

466

386

358

338

324

323

327

327

339

351

360

365

368

364

358

351

343

327

304

279

258

249

251

250

247

242

228

201

169

136

110

100

97

0

0

0

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

-0

1

1

1

0

0

0

Stock-based compensation

3,043

2,295

2,023

1,752

1,519

1,443

1,374

1,313

1,313

1,270

1,150

1,017

960

776

758

755

624

511

382

278

211

229

255

269

232

248

237

206

236

216

206

201

203

235

0

0

0

Amortization of deferred rent related to lease incentives

-

0

0

95

-

126

126

127

-

127

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non cash lease expense

-512

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense – finance type lease

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

210

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Stock to be issued for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Write off of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13

27

41

55

56

60

64

65

78

181

89

86

74

0

0

0

Amortization of deferred rent related to lease incentives

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount

-

-

-

-

-

-

-

-

-

156

249

343

311

218

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from equity method investment in SAVSU

-739

-1,048

-799

-760

-672

-660

-836

-919

-919

-1,005

-707

-489

-229

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred rent related to lease incentives

-

-

-

-

-

-

-

-

-

-

-

-

-

126

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease incentives received from landlord, net of amortization of deferred rent related to lease incentives

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-37

-157

-151

25

52

183

200

848

861

0

0

0

-

-

-

-

Accretion and amortization on available for sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

-10

-26

-51

-90

-126

-143

-138

-98

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in operating assets and liabilities
Accounts receivable, trade, net

290

718

1,511

1,883

2,024

1,346

993

-16

-16

-172

42

-110

-129

264

518

474

339

27

17

242

-474

-107

601

-414

1,101

409

-228

139

-504

-53

-339

36

-115

-208

0

0

0

Inventories

3,777

2,328

2,728

2,223

1,662

1,049

352

24

24

89

324

226

161

290

120

589

775

869

1,065

643

945

544

-185

85

-339

-235

440

197

87

-150

-374

-407

-316

-95

0

0

0

Prepaid expenses and other current assets

-

0

0

110

-

128

148

30

-

181

-1

12

82

-73

-71

82

39

-15

126

-14

39

23

65

116

55

117

-17

-107

-133

-84

-32

-10

9

-28

0

0

0

Accounts payable

768

23

-215

611

-11

591

313

-36

-36

21

-356

-98

129

233

302

501

65

194

559

204

-12

-392

-671

-871

-345

4

-223

510

519

459

753

184

257

286

0

0

0

Accrued compensation and other current liabilities

-

0

0

296

-

358

239

149

-

292

-163

-391

-379

-410

-77

159

218

-145

17

64

65

7

186

55

-70

278

3

58

180

227

87

75

-39

-59

0

0

0

Accrued interest

-

-

-

-

-

-

-

-

-

152

210

274

181

97

0

0

0

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-8

-5

-

-65

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest, related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

742

742

742

740

733

0

0

0

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

27

31

34

45

36

87

71

49

39

-8

10

23

0

21

56

54

76

0

0

0

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,214

-5,259

-4,973

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest, related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-109

-114

-277

-124

-20

-20

138

-20

-20

0

0

0

Net cash provided by operating activities

1,213

2,801

2,474

3,102

2,348

2,565

1,830

1,166

1,166

605

0

0

0

-

-

-

-

-

-

-

-

-3,162

-2,386

-1,701

-621

146

236

248

803

854

493

239

-760

-989

0

0

0

Cash flows from investing activities
Sales of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Investment in equity investment SAVSU

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,409

1,409

2,229

8,294

7,952

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Sales/maturities of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

1,650

2,892

3,992

6,617

7,067

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash received from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

2

2

2

2

0

0

0

Costs associated with internal use software development

-

-

-

-

-

-

-

-

-

-

-

-

-

1,113

1,246

1,481

1,836

1,283

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property and equipment

675

517

706

615

500

391

126

147

147

144

104

122

153

143

160

161

119

134

446

563

612

589

248

108

221

236

214

354

1,138

1,151

1,208

1,073

127

93

0

0

0

Net cash used in investing activities

-27,018

-13,158

-18,144

-6,615

-6,500

-6,391

-1,126

-147

-147

-144

0

0

0

-

-

-

-

-

-

-

-

-8,135

-8,094

-6,174

-221

-236

-214

-353

-1,137

-1,150

-1,205

-1,070

-124

-91

0

0

0

Cash flows from financing activities
Proceeds from note payable

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

0

25

325

475

700

950

920

1,095

0

0

0

Payments on equipment loan

-

0

0

13

-

10

9

16

-

13

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on finance lease obligations

-

0

0

14

-

13

13

14

-

11

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,282

3,594

4,239

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of common stock options

1,181

-9,822

-7,790

563

508

14,917

12,562

3,931

3,988

3,978

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash received in advance of issuance of stock on warrant exercises

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of preferred stock dividends

-

-

-

-

436

412

319

212

212

106

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of common stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

82

108

83

80

131

50

50

50

0

0

0

0

0

0

-

-

-

-

Deferred costs paid related to potential stock issuance

-

-

-

-

-

-

-

-

-

43

67

67

121

111

86

86

20

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,353

355

368

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of common stock, net of expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,596

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

1,596

-819

21,121

28,304

28,146

33,375

11,147

3,723

3,724

4,796

0

0

0

-

-

-

-

-

-

-

-

13,679

13,676

13,701

13,621

50

50

25

325

475

700

950

920

1,095

0

0

0

Net increase (decrease) in cash and cash equivalents

-24,209

-11,176

5,451

24,791

23,994

29,550

11,851

4,741

4,742

5,257

1,461

996

627

-767

-982

-2,577

-1,309

-365

-923

-2,005

-9,867

2,382

3,195

5,826

12,778

-40

71

-79

-9

179

-12

119

35

13

0

0

0

Costs incurred for capitalized internal use software not paid as of quarter end (amounts are included in liabilities)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash investing and financing activities
Purchase of property and equipment not yet paid

29

0

0

0

-

-

-

-

-

22

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs from issuance of warrants (See Note 7)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Conversion of notes payable and related party accrued interest to equity, net of unamortized deferred finance costs (See Note 1)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,180

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Costs incurred for capitalized internal use software not paid as of quarter end (amounts are included in liabilities)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Option exercises for which cash not yet received as of quarter end

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued for services in prior period included in liabilities at prior year-end

-

-

-

-

36

36

36

36

36

36

35

35

35

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of warrant liabilities to equity upon exercise

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of equipment with debt

-

-

-

-

18

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred costs related to security issuance not yet paid as of quarter end

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-